HIK — Hikma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00
- £4.20bn
- £4.98bn
- $2.88bn
- 87
- 49
- 95
- 93
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Final Results
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Potential Acquisition
AnnouncementREG - Hikma Pharmaceutical - Hikma provides update on generic Advair Diskus®
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Hikma launches generic Advair Diskus®
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementRCS - Vectura Group plc - Vectura agreement with Kinaset Therapeutics Inc.
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Directorate Change
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Hikma launches Icosapent Ethyl Capsules
Announcement